VCYTMID

Veracyte, Inc.

HealthcareBiotechnology
$40.76
$0.00(-1.04%)
52W$22.61
$50.71
Updated May 8, 12:00 AM
RSI73
RS Rating34/99
Beta1.52
Volatility54%
F-Score8/9
Mkt Cap$3.3B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Veracyte, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 34), showing significant lag compared to the market leaders. Earnings growth of 298% provides fundamental context to the price action. However, price is extended 22% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
34
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.52
vs S&P 500
HIGH BETA
52W Position
65%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$33.51
50 SMA > 100 SMA$36.87
100 SMA > 150 SMA$37.83
150 SMA > 200 SMA$35.80

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$34.01+19.83%ABOVE
50 SMA$33.51+21.65%ABOVE
100 SMA$36.87+10.56%ABOVE
150 SMA$37.83+7.73%ABOVE
200 SMA$35.80+13.87%ABOVE

Price Performance

1D-1.0%
1W+23.8%
1M+26.8%
3M+11.0%
6M-2.3%
YTD-3.8%
1Y+32.2%
3Y+21.7%
52-Week Trading Range65% from low
$40.76
52W Low$22.61
52W High$50.71

Technical Indicators

RSI (14)OVERBOUGHT
73.3
305070
VCP ScoreCOOL
2/10
Base depth: 31.0%

Risk Profile

Beta
1.52
52W Vol
54%
ATR
$1.42
Max DD (1Y)
-39%

Volume Analysis

Today
1.67M
50D Avg
886.9K
Vol Ratio
1.88x
Liquidity
MODERATE

Earnings Momentum

Q2'25-118%
$-0.01
Q3'25+26%
$0.24
Q4'25+733%
$0.50
Q1'26+298%
$0.35
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+26.44%
5 Years:+34.50%
3 Years:+20.37%
TTM:+16.91%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+164.09%

Stock Price CAGR

10 Years:+22.13%
5 Years:-1.67%
3 Years:+21.67%
1 Year:+32.17%

Return on Equity

10Y Avg:-19.1%
5Y Avg:-2.6%
3Y Avg:0.2%
Last Year:6.9%

Key Metrics

Market Cap$3.3B
Gross Margin69.6%
Net Margin12.8%
Piotroski F-Score8/9

Frequently Asked Questions

Is VCYT in an uptrend right now?

VCYT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is VCYT overbought or oversold?

VCYT's RSI (14) is 73. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is VCYT outperforming the market?

VCYT has a Relative Strength (RS) Rating of 34 out of 99. VCYT is currently lagging the broader market.

Where is VCYT in its 52-week range?

VCYT is trading at $40.76, which is 80% of its 52-week high ($50.71) and 65% above its 52-week low ($22.61).

How volatile is VCYT?

VCYT has a Beta of 1.52 and 52-week volatility of 54%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.